MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Is primary writing tremor a form fruste of dystonia?

    A. Latorre, L. Rocchi, A. Berardelli, J. Rothwell, K. Bhatia (Rome, Italy)

    Objective: To investigate whether primary writing tremor (PWT) and dystonia share a common pathophysiology and clarify if they are different phenomenological expressions of the same…
  • 2019 International Congress

    Social Cognition, Neuropsychological functioning & Mood Disorder in Cervical Dystonia (CD)

    R. Monaghan, D. Mccormack, I. Ndukwe, T. Burke, N. Pender, S. O’Riordan, M. Hutchinson, F. O'Keeffe (Dublin, Ireland)

    Objective: This study investigated social cognition, neuropsychological functioning and mood disorder in CD. Background: CD is a hyperkinetic movement disorder of unknown cause. Although historically…
  • 2019 International Congress

    Striatal dopaminergic dysregulation and dystonia-like movements induced by peripheral nerve crush in a transgene DYT1 mouse model

    L. Rauschenberger, A. Stengl, S. Knorr, K. Grundmann-Hauser, J. Volkmann, CW. Ip (Würzburg, Germany)

    Objective: To study changes of the dopaminergic pathway of a transgene DYT1 dystonia mouse model after induction of a dystonic phenotype by peripheral nerve crush.…
  • 2019 International Congress

    Effect of Botulinum Toxin Treatment on Cervical Dystonia

    S. Tomic, M. Tomasevic, D. Hardi, T. Gilman Kuric, Z. Popovic (Osijek, Croatia)

    Objective: To find out influence of botulinum toxin (BonT) treatment on improvement of motor symptoms and pain.To find out influence of botulinum toxin (BonT) treatment…
  • 2019 International Congress

    Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE

    A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)

    Objective: To identify patient demographics and clinical characteristics that impact onabotulinumtoxinA treatment adherence from the Adult Spasticity International Registry (ASPIRE) study. Background: A better understanding…
  • 2019 International Congress

    Ecopipam, a selective D1 antagonist in development for the treatment of Tourette syndrome in children and adolescents: The Phase 2b D1AMOND Study

    J. Dubow, D. Kim, R. Bittman, S. Wanaski, J. Swalec, T. Cunniff (Northbrook, IL, USA)

    Objective: To describe the Phase 2b study design and optimized dosing strategy to evaluate the efficacy and safety of ecopipam in children and adolescent subjects…
  • 2019 International Congress

    Is there evidence of bradykinesia in patients with Essential Tremor?

    D. Colella, M. Bologna, G. Paparella, A. Cannavacciuolo, S. Pietracupa, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: To evaluate possible abnormalities (bradykinesia) of repetitive finger movements, including the sequence effect, using kinematic techniques in patients with ET. Background: Essential tremor (ET)…
  • 2019 International Congress

    Different patterns of cortical and subcortical perfusion changes in essential tremor and tremor-dominant Parkinson’s disease using voxel-based analysis of 3D arterial spin-labeling imaging

    L. Jin, J. Wang, C. Wang (Shanghai, China)

    Objective: We aimed to evaluate cerebral blood flow (CBF) in patients with untreated ET, de novo tremor-dominant PD (PDT) and age- and gender- matched controls…
  • 2019 International Congress

    ADL impairment and quality of life in patients with essential tremor

    P. Reker, S. Schnitzler, T. Thies, A. Josten, J. Becker, J. Steffen, J. Wirths, H. Dafsari, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)

    Objective: To investigate the relationship of tremor severity, disease related quality of life (QoL) and impairment of activities of daily living (ADL) in patients with…
  • 2019 International Congress

    Substantia Nigra Hyperechogenicity in Parkinson’s Disease and Essential Tremor and its Association with Premotor Symptoms of Parkinson’s Disease

    M. Uribe Roca, A. Chertcoff, L. Bandeo, M. Saucedo, F. Pantiu, L. de Francesco, L. Leon Cejas, M. Pacha, G. Napoli, P. Bonardo, O. Martinez, M. Fernandez Pardal, R. Reisin (Buenos Aires, Argentina)

    Objective: To compare the frequency of Substantia Nigra hyperechogenicity (SN+) in patients with essential tremor (ET) and Parkinson’s disease (PD), to determine the frequency of…
  • « Previous Page
  • 1
  • …
  • 156
  • 157
  • 158
  • 159
  • 160
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • DaTscan in clinical evaluation of Multiple System Atrophy
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley